Moore Capital Management LP Takes $903,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Moore Capital Management LP bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 38,929 shares of the company’s stock, valued at approximately $903,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP lifted its position in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after acquiring an additional 8,400,208 shares during the period. Norges Bank acquired a new position in shares of Option Care Health in the fourth quarter valued at $60,219,000. Freestone Grove Partners LP bought a new position in Option Care Health in the fourth quarter worth $17,487,000. Dimensional Fund Advisors LP boosted its stake in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock worth $92,518,000 after buying an additional 591,042 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock valued at $49,310,000 after buying an additional 503,840 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on OPCH shares. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. boosted their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $35.50.

Option Care Health Stock Performance

NASDAQ OPCH opened at $31.56 on Wednesday. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a 50 day moving average of $33.13 and a 200-day moving average of $28.92. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.17 billion, a price-to-earnings ratio of 26.52, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.26 billion. During the same period last year, the firm posted $0.26 EPS. The business’s revenue was up 16.3% on a year-over-year basis. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.